Researchers have discovered small molecules that kill cancer cells caused by infection with human papillomavirus. Their results, in both cell and mouse models, demonstrate that the small molecule inhibitors protect a tumor-suppressing protein targeted by viral proteins, thus killing the infected tumor cells. The researchers believe that, with further testing and refinement, their inhibitors could provide a therapeutic for HPV-caused tumors, such as those seen in cervical cancer.
- Blocking molecular target could make more cancers treatable with PARP inhibitorsWed, 29 Jun 2011, 15:34:38 EDT
- Cancer-causing bacterium targets tumor-suppressor proteinMon, 2 Aug 2010, 6:21:54 EDT
- PARP inhibitor, MK-4827, shows anti-tumor activity in first trial in humansWed, 17 Nov 2010, 22:37:09 EST
- Small molecule may disarm enemy of cancer-fighting p53Tue, 7 Dec 2010, 16:36:11 EST
- 2 drugs are better than 1 at targeting tumors with B-RAF mutationsFri, 24 Oct 2008, 6:08:40 EDT